Skip to main content

Main menu

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • COVID-19
    • Articles & podcasts
    • Blog posts
    • Collection
    • News
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • Classified ads
  • Authors
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
  • CMA Members
    • Overview for members
    • Earn CPD Credits
    • Print copies of CMAJ
    • Career Ad Discount
  • Subscribers
    • General information
    • View prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Letters

Don’t foredoom cannabis legalization to failure

Michael J. Armstrong and Dan Malleck
CMAJ January 21, 2019 191 (3) E84; DOI: https://doi.org/10.1503/cmaj.71136
Michael J. Armstrong
Associate professor, Goodman School of Business, Brock University, St. Catharines, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dan Malleck
Associate professor, Faculty of Applied Health Sciences, Brock University, St. Catharines, Ont.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Responses
  • Metrics
  • PDF
Loading

In her recent editorial, Dr. Diane Kelsall proposes a simplistic standard for evaluating cannabis legalization: if cannabis use rises, then legalization fails. That does a disservice to medicine and to Canadians, because such a standard is unachievable, narrow-minded and counterproductive.

It is unachievable because cannabis use will rise with any liberalization. Decreasing the cannabis “price” (i.e., its legal penalties) will result in increased use; that is basic economics. The extent of business involvement and product advertising might affect the size of that increase size, but not its occurrence.

It is narrow-minded because it implies limiting cannabis use is society’s only objective. But legalization affects the well-being of Canadians in many ways. For example, reducing incarceration rates and criminal revenues are also valuable societal goals. A good public policy does not pursue perfection along a single dimension. Rather, it achieves the best compromise among many competing goals.

It is counterproductive because what is important to reduce is not cannabis use, but rather its harms. Legalization allows more openness around cannabis, possibly encouraging problematic users to seek treatment. It lets users buy regulated products, rather than products possibly contaminated by mould, pesticide or fentanyl. It is therefore possible that even increased use could be accompanied by decreased overall harm.

Personally, we neither use cannabis nor promote its use. But professionally, we encourage governments to implement realistic policies offering the “least bad” way of dealing with cannabis. We encourage Dr. Kelsall to do the same, rather than foredooming legalization to failure.

Footnotes

  • Competing interests: None declared.

Reference

    1. Kelsall D
    . Watching Canada’s experiment with legal cannabis. CMAJ 2018;190:E1218.
    OpenUrlFREE Full Text
PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 191 (3)
CMAJ
Vol. 191, Issue 3
21 Jan 2019
  • Table of Contents
  • Index by author

Article tools

Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Don’t foredoom cannabis legalization to failure
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Don’t foredoom cannabis legalization to failure
Michael J. Armstrong, Dan Malleck
CMAJ Jan 2019, 191 (3) E84; DOI: 10.1503/cmaj.71136

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Don’t foredoom cannabis legalization to failure
Michael J. Armstrong, Dan Malleck
CMAJ Jan 2019, 191 (3) E84; DOI: 10.1503/cmaj.71136
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Footnotes
    • Reference
  • Responses
  • Metrics
  • PDF

Related Articles

  • Watching Canada’s experiment with legal cannabis
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Moving surgical care out of hospitals to reduce wait times
  • Coexisting failures do not diminish the stature of a giant
  • Dare we hope
Show more Letters

Similar Articles

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions

Copyright 2021, Joule Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

Powered by HighWire